Skip to main content
SpringerLink
Log in

Aflibercept/bevacizumab/ranibizumab

Membranous nephropathy, Renal allograft proteinuria and antibody mediated injury: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cheungpasitporn W, et al. Kidney transplant recipient with proteinuria and subsequent membranous nephropathy after intravitreal anti-VEGF therapy. American Journal of Kidney Diseases 63: A38, No. 5, May 2014. Available from: URL: http://doi.org/10.1053/j.ajkd.2014.01.096

  2. Chebib F, et al. Intravitreal anti-vascular endothelial growth factor (VEGF) therapy may induce renal allograft poroteinuria and antibody mediated injury. American Journal of Kidney Diseases 63: A37, No. 5, May 2014

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aflibercept/bevacizumab/ranibizumab. Reactions Weekly 1579, 24 (2015). https://doi.org/10.1007/s40278-015-10985-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-10985-4

Search

Navigation